Determinants of participation in colorectal cancer screening with faecal occult blood testing

被引:58
|
作者
von Euler-Chelpin, My [1 ]
Brasso, Klaus [2 ]
Lynge, Elsebeth [1 ]
机构
[1] Univ Copenhagen, Dept Publ Hlth, DK-1014 Copenhagen, Denmark
[2] Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark
关键词
cancer; screening; socio-economics factors; RANDOMIZED CONTROLLED-TRIAL; BASE-LINE FINDINGS; FLEXIBLE SIGMOIDOSCOPY; COLON-CANCER; SOCIOECONOMIC DEPRIVATION; DEMONSTRATION PILOT; UNITED-KINGDOM; POPULATION; SURVIVAL; PREDICTORS;
D O I
10.1093/pubmed/fdp115
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Colorectal cancer is one of the most common cancers in men and women. Participation rates in faecal occult blood testing (FOBT) screening activities are, however, relatively low. In terms of lowering the colorectal cancer mortality, high participation rates are essential, and therefore it is important to understand the barriers to FOBT screening. We undertook a systematic search through PUBMED, Medline, EMBASE and PsycINFO in order to identify studies that provide information on socio-demographic determinants of participation in FOBT screening. FOBT participation varied considerably across countries, but they have rarely been above 60%. The use of other health-care services was in most studies a strong determinant for participation in screening with FOBT. There was a tendency to higher participation among women than among men and among married as opposed to not married, but determinants varied across countries and test settings. There was no systematic variation in participation across age groups. The participation pattern depends in part on local circumstances, which makes it difficult to point to a general strategy for increasing the uptake in FOBT screening. This stresses the need for monitoring of individual screening programmes and developing information strategies targeted to the local participation pattern.
引用
下载
收藏
页码:395 / 405
页数:11
相关论文
共 50 条
  • [21] Review article: faecal occult blood testing for colorectal cancer
    Allison, JE
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (01) : 1 - 10
  • [22] Faecal occult blood testing in the secondary prevention of colorectal cancer
    Kronborg, O
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (02) : 167 - 168
  • [23] What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam, L.
    Korfage, I. J.
    Kuipers, E. J.
    Hol, L.
    van Roon, A. H. C.
    Reijerink, J. C. I. Y.
    van Ballegooijen, M.
    van Leerdam, M. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (10) : 2321 - 2330
  • [24] Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer
    Hunt, LM
    Rooney, PS
    Bostock, K
    Robinson, MHE
    Hardcastle, JD
    Armitage, NC
    GUT, 1997, 40 (01) : 110 - 112
  • [25] SCREENING FOR COLORECTAL CANCER Interval bowel cancers may not be detected on faecal occult blood testing
    George, Anil Thomas
    Aggarwal, Smeer
    Fields, Andrew
    Vogler, Mike
    Menon, Achyuth
    Dube, Mukul
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [26] Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
    Holme, Oyvind
    Bretthauer, Michael
    Fretheim, Atle
    Odgaard-Jensen, Jan
    Hoff, Geir
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09):
  • [27] Rawl's questionnaire spanish validation for colorectal cancer screening with faecal occult blood testing
    Menendez Rodriguez, Martin
    Garau Ramirez, Jorge
    Traver Salvador, Alba
    Hervas Jimenez, Yesica
    Garcia Morales, Natalia
    Seoane Pillado, Teresa
    Pin Vieito, Noel
    Vega Villaamil, Pablo
    Montes Martinez, Agustin
    Cubiella, Joaquin
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (02): : 106 - 113
  • [28] Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia
    Salkeld, G
    Young, G
    Irwig, L
    Haas, M
    Glasziou, P
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1996, 20 (02) : 138 - 143
  • [29] Colorectal cancer screening with faecal occult blood testing: Community intention, knowledge, beliefs and behaviour
    Tong, S.
    Hughes, K.
    Oldenburg, B.
    Mar, C. D.
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2006, 18 (01) : 16 - 23
  • [30] Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?
    Haug, Ulrike
    Grobbee, Esmee J.
    Lansdorp-Vogelaar, Iris
    Spaander, Manon C. W.
    Kuipers, Ernst J.
    GUT, 2017, 66 (07) : 1262 - 1267